PDT Partners LLC lowered its holdings in Varex Imaging Co. (NASDAQ:VREX - Free Report) by 25.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 112,344 shares of the company's stock after selling 38,867 shares during the period. PDT Partners LLC owned about 0.27% of Varex Imaging worth $1,639,000 as of its most recent SEC filing.
A number of other institutional investors have also recently bought and sold shares of VREX. Barclays PLC boosted its holdings in shares of Varex Imaging by 1.1% in the 4th quarter. Barclays PLC now owns 98,964 shares of the company's stock worth $1,444,000 after buying an additional 1,081 shares during the last quarter. Isthmus Partners LLC raised its position in Varex Imaging by 0.8% in the fourth quarter. Isthmus Partners LLC now owns 149,874 shares of the company's stock worth $2,187,000 after acquiring an additional 1,260 shares during the period. Quadrant Capital Group LLC boosted its stake in Varex Imaging by 115.4% in the fourth quarter. Quadrant Capital Group LLC now owns 2,837 shares of the company's stock valued at $41,000 after acquiring an additional 1,520 shares during the last quarter. Aquatic Capital Management LLC bought a new position in shares of Varex Imaging during the 4th quarter valued at approximately $25,000. Finally, MetLife Investment Management LLC increased its stake in shares of Varex Imaging by 8.5% during the 4th quarter. MetLife Investment Management LLC now owns 24,026 shares of the company's stock worth $351,000 after purchasing an additional 1,890 shares during the last quarter.
Wall Street Analyst Weigh In
Several equities analysts recently commented on VREX shares. StockNews.com upgraded Varex Imaging from a "hold" rating to a "buy" rating in a research note on Friday, February 7th. Oppenheimer dropped their price target on Varex Imaging from $30.00 to $23.00 and set an "outperform" rating on the stock in a research report on Friday, February 7th. Finally, B. Riley reissued a "buy" rating and issued a $22.00 price objective (up previously from $21.00) on shares of Varex Imaging in a report on Friday, February 7th.
Get Our Latest Report on Varex Imaging
Varex Imaging Stock Performance
VREX traded up $0.32 on Friday, hitting $8.71. The company's stock had a trading volume of 326,687 shares, compared to its average volume of 573,135. The company's 50 day simple moving average is $10.35 and its 200-day simple moving average is $12.86. The company has a quick ratio of 2.50, a current ratio of 4.36 and a debt-to-equity ratio of 1.02. Varex Imaging Co. has a 12 month low of $6.97 and a 12 month high of $16.93. The firm has a market cap of $358.85 million, a P/E ratio of -7.44 and a beta of 0.62.
Varex Imaging (NASDAQ:VREX - Get Free Report) last announced its quarterly earnings results on Thursday, February 6th. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.03. Varex Imaging had a positive return on equity of 4.00% and a negative net margin of 5.79%. Analysts forecast that Varex Imaging Co. will post 0.53 EPS for the current year.
Insider Transactions at Varex Imaging
In other Varex Imaging news, CEO Sunny Sanyal sold 8,749 shares of the company's stock in a transaction dated Wednesday, April 2nd. The stock was sold at an average price of $11.24, for a total value of $98,338.76. Following the transaction, the chief executive officer now directly owns 190,193 shares in the company, valued at $2,137,769.32. This represents a 4.40 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Kimberley E. Honeysett sold 4,007 shares of the firm's stock in a transaction dated Thursday, March 20th. The shares were sold at an average price of $12.81, for a total value of $51,329.67. Following the completion of the sale, the senior vice president now directly owns 4,002 shares in the company, valued at approximately $51,265.62. The trade was a 50.03 % decrease in their position. The disclosure for this sale can be found here. Insiders own 4.30% of the company's stock.
Varex Imaging Company Profile
(
Free Report)
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
Further Reading
Before you consider Varex Imaging, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Varex Imaging wasn't on the list.
While Varex Imaging currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
